| 4 | Statement of changes in beneficial owner... | Roth David | Donnelley Financial Solutions /fa | 11/20/2024 | |
| 4 | Statement of changes in beneficial owner... | Syros Pharmaceuticals, Inc. | Donnelley Financial Solutions /fa | 11/20/2024 | |
| 144 | Filing for proposed sale of securities u... | Syros Pharmaceuticals, Inc. | E Trade Financial Corp Llc Et Middle Office / Fa /fa | 11/18/2024 | |
| 144 | Filing for proposed sale of securities u... | Roth David | E Trade Financial Corp Llc Et Middle Office / Fa /fa | 11/18/2024 | |
| 4 | Statement of changes in beneficial owner... | Roth David | Donnelley Financial Solutions /fa | 11/04/2024 | |
| 4 | Statement of changes in beneficial owner... | Syros Pharmaceuticals, Inc. | Donnelley Financial Solutions /fa | 11/04/2024 | |
| 4 | Statement of changes in beneficial owner... | Roth David | Donnelley Financial Solutions /fa | 04/05/2024 | |
| 4 | Statement of changes in beneficial owner... | Syros Pharmaceuticals, Inc. | Donnelley Financial Solutions /fa | 04/05/2024 | |
| 144 | Filing for proposed sale of securities u... | Roth David | Ubs Financial Services Inc. - 10b5-1 Group / Fa /fa | 04/03/2024 | |
| 144 | Filing for proposed sale of securities u... | Syros Pharmaceuticals, Inc. | Ubs Financial Services Inc. - 10b5-1 Group / Fa /fa | 04/03/2024 | |
| Load More |